LOTUSEYENSELotus Eye Hospital and Institute Limited· Healthcare ServicesHighPositive
Announced Mon, 22 Sept, 2025 · 11:48 IST

Promoter Sangeetha acquires 5.4956% stake from promoter Kavetha

Promoter Stake BuyPromoter Stake Sell 1pctPromoter Below 50pctOwnership Changes View source PDFExplain this filing

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹120.24
prior close
₹119.20
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+1.0% vs market
Hospital peers, median of 20sector-0.2%+0.4% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.3
10m
+3.2
15m
+3.1
30m
+3.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2-0.7+1.0-0.2+0.4
Next day
+1.5-1.0+2.5-0.2+1.6
2d
-0.9-1.4+0.5-1.9+0.9
3d
-1.0-2.4+1.4-1.7+0.6
4d
-0.4-4.5+4.1-2.7+2.4
5d
-0.3-5.3+5.0-3.4+3.2
1w
+2.3-4.3+6.6-2.9+5.2
15d
+1.5-4.6+6.1-0.2+1.6
1m
-1.8-2.2+0.4+2.0-3.8
2m
-12.7-5.6-7.1+1.3-14.0
3m
+3.8-6.6+10.5-4.2+8.0
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On 18 September 2025, promoter Sangeetha Sundaramoorthy bought 11,42,900 shares at Rs 70 each from promoter Kavetha Sundarmoorthy under a 2 June 2025 share purchase agreement. The transfer equalled 5.4956% of diluted capital, lifting Sangeetha's stake to 28.1092% and reducing Kavetha's to 9.6149%. The filing states no open offer was required.

Likely market impact

This promoter-to-promoter transfer shifts voting power within the promoter group. It adds no shares, causes no dilution and requires no open offer.